JP2021059508A - 腸内環境改善剤 - Google Patents
腸内環境改善剤 Download PDFInfo
- Publication number
- JP2021059508A JP2021059508A JP2019183809A JP2019183809A JP2021059508A JP 2021059508 A JP2021059508 A JP 2021059508A JP 2019183809 A JP2019183809 A JP 2019183809A JP 2019183809 A JP2019183809 A JP 2019183809A JP 2021059508 A JP2021059508 A JP 2021059508A
- Authority
- JP
- Japan
- Prior art keywords
- bacteria
- intestinal environment
- improving agent
- acacia
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 22
- 241000220479 Acacia Species 0.000 claims abstract description 19
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims abstract description 19
- 241000894006 Bacteria Species 0.000 claims description 36
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 9
- 241000186000 Bifidobacterium Species 0.000 claims description 7
- 210000000936 intestine Anatomy 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 241000993444 Acacia mearnsii Species 0.000 claims description 4
- 241000186660 Lactobacillus Species 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 229940039696 lactobacillus Drugs 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 description 2
- 241000278701 Acacia mangium Species 0.000 description 2
- 235000017631 Acacia mangium Nutrition 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- MJBPUQUGJNAPAZ-AWEZNQCLSA-N butin Chemical compound C1([C@@H]2CC(=O)C3=CC=C(C=C3O2)O)=CC=C(O)C(O)=C1 MJBPUQUGJNAPAZ-AWEZNQCLSA-N 0.000 description 2
- GMPPKSLKMRADRM-SWLSCSKDSA-N robinetinidol Chemical compound C1([C@H]2OC3=CC(O)=CC=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 GMPPKSLKMRADRM-SWLSCSKDSA-N 0.000 description 2
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- DSCFFEYYQKSRSV-UHFFFAOYSA-N 1L-O1-methyl-muco-inositol Natural products COC1C(O)C(O)C(O)C(O)C1O DSCFFEYYQKSRSV-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 241001199697 Acacia dealbata Species 0.000 description 1
- 244000236161 Acacia decurrens Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- MJBPUQUGJNAPAZ-UHFFFAOYSA-N Butine Natural products O1C2=CC(O)=CC=C2C(=O)CC1C1=CC=C(O)C(O)=C1 MJBPUQUGJNAPAZ-UHFFFAOYSA-N 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- VJXUJFAZXQOXMJ-UHFFFAOYSA-N D-1-O-Methyl-muco-inositol Natural products CC12C(OC)(C)OC(C)(C)C2CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 VJXUJFAZXQOXMJ-UHFFFAOYSA-N 0.000 description 1
- DSCFFEYYQKSRSV-KLJZZCKASA-N D-pinitol Chemical compound CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-KLJZZCKASA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920001991 Proanthocyanidin Polymers 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 229930182448 Prodelphinidin Natural products 0.000 description 1
- 229920000124 Prodelphinidin Polymers 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- GMPPKSLKMRADRM-UHFFFAOYSA-N Robidanol Natural products OC1CC2=CC=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 GMPPKSLKMRADRM-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- KQNGHARGJDXHKF-UHFFFAOYSA-N dihydrotamarixetin Natural products C1=C(O)C(OC)=CC=C1C1C(O)C(=O)C2=C(O)C=C(O)C=C2O1 KQNGHARGJDXHKF-UHFFFAOYSA-N 0.000 description 1
- VFZYLYJWCROVLO-UHFFFAOYSA-N ent-Fisetidinol Natural products OC1CC2=CC=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 VFZYLYJWCROVLO-UHFFFAOYSA-N 0.000 description 1
- VFZYLYJWCROVLO-DZGCQCFKSA-N fisetinidol Chemical compound C1([C@H]2OC3=CC(O)=CC=C3C[C@@H]2O)=CC=C(O)C(O)=C1 VFZYLYJWCROVLO-DZGCQCFKSA-N 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- -1 prolobinetinidin Chemical compound 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
アカシア(Acacia mearnsii De Wild.)の樹皮を粉砕し、100℃の熱水で抽出した。得られた溶液をスプレードライヤーで噴霧乾燥し、熱水抽出物を得た。
(実験動物)
雌性BALB/cマウスを、コントロール群(n=8)、及び投与群(n=8)に分けた。22日間、コントロール群には普通飼料を経口投与し、投与群にはアカシア樹皮抽出物3%含有飼料を経口投与した。22日目に各群のマウスの糞を採取した。
なお、マウスは温度24±1℃、湿度55±5%の施設において飼育し、明暗条件は8:00点灯、20:00消灯とした。
1.DNAの抽出・調整方法
糞からの細菌DNAの抽出はQIAamp DNA stool mini kit (Qiagen, Inc)を用いて行った。抽出方法はQIAamp DNA stool mini kit付属のプロトコールに従った。得られた溶液を、微量分光光度計にて260nm及び280nmの吸光度を測定することで、純度の確認及びDNA濃度(ng/μL)の算出を行った。
各種プライマーを作成し、リアルタイムPCRにより、ビフィドバクテリウム属の菌、及びラクトバチルス属の菌を検出した。PCRプレートの各ウェルへSsoAdvanced Universal SYBR Green Supermix 5μL、目的遺伝子のforward primer(5pmol/μL) 0.6μL、reverse primer(5pmol/μL) 0.6μL、DNA溶液 2μL、RNase free water 2.8μLを加えた。PCR条件は、denaturation温度として95℃で30sec、annealing温度として58℃で30sec、elongation温度として72℃で60secとした。増幅過程の蛍光強度をCFX Connect Real-Time System(Bio-Rad Laboratories)によりモニタリングした。発現量は、16SrRNAを用いてノーマライズした。
結果を図1に示す。糞中のビフィドバクテリウム属の菌の量が、投与群では、コントロール群と比較して、約3倍に増加していた。また、糞中のラクトバチルス属の菌の量が、投与群では、コントロール群と比較して、約2倍に増加していた。
Claims (7)
- アカシアの樹皮の抽出物を含む、腸内環境改善剤。
- 前記腸内環境改善が、腸内の善玉菌の増加である、請求項1に記載の腸内環境改善剤。
- 前記善玉菌が、乳酸菌及び/又はビフィズス菌である、請求項2に記載の腸内環境改善剤。
- 前記善玉菌が、ラクトバチルス(Lactbacillus)属の菌及び/又はビフィドバクテリウム(Bifidobacterium)属の菌である、請求項2に記載の腸内環境改善剤。
- 前記アカシアが、Acacia mearnsii De Wild.である、請求項1〜4のいずれか一項に記載の腸内環境改善剤。
- 食品である、請求項1〜5のいずれか一項に記載の腸内環境改善剤。
- 医薬品又は医薬部外品である、請求項1〜5のいずれか一項に記載の腸内環境改善剤。
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019183809A JP2021059508A (ja) | 2019-10-04 | 2019-10-04 | 腸内環境改善剤 |
PCT/JP2020/037091 WO2021065987A1 (ja) | 2019-10-04 | 2020-09-30 | 腸内環境改善剤 |
US17/766,044 US20220370533A1 (en) | 2019-10-04 | 2020-09-30 | Intestinal-environment-improving agent |
KR1020227012433A KR20220062388A (ko) | 2019-10-04 | 2020-09-30 | 장내 환경 개선제 |
EP20871159.8A EP4039262A4 (en) | 2019-10-04 | 2020-09-30 | AGENTS FOR IMPROVING THE INTESTINAL ENVIRONMENT |
CN202080069943.3A CN114502186A (zh) | 2019-10-04 | 2020-09-30 | 肠内环境改善剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019183809A JP2021059508A (ja) | 2019-10-04 | 2019-10-04 | 腸内環境改善剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021059508A true JP2021059508A (ja) | 2021-04-15 |
Family
ID=75336423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019183809A Pending JP2021059508A (ja) | 2019-10-04 | 2019-10-04 | 腸内環境改善剤 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220370533A1 (ja) |
EP (1) | EP4039262A4 (ja) |
JP (1) | JP2021059508A (ja) |
KR (1) | KR20220062388A (ja) |
CN (1) | CN114502186A (ja) |
WO (1) | WO2021065987A1 (ja) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002003388A (ja) * | 2000-06-20 | 2002-01-09 | Nof Corp | 便秘解消剤組成物 |
JP2009120508A (ja) * | 2007-11-13 | 2009-06-04 | Mimozax Co Ltd | アカシア属樹皮由来物を含有する便通改善用組成物 |
JP2009161502A (ja) * | 2008-01-10 | 2009-07-23 | Rikomu:Kk | 腸内菌叢改善剤及び食品 |
JP2013249276A (ja) * | 2012-05-31 | 2013-12-12 | Tsutsumi Planning:Kk | 機能食品 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003238416A (ja) * | 2002-02-13 | 2003-08-27 | Kureo Internatl Kk | 腸内細菌改善組成物 |
US7108868B2 (en) * | 2002-03-22 | 2006-09-19 | Unigen Pharmaceuticals, Inc. | Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
WO2008018139A1 (en) * | 2006-08-10 | 2008-02-14 | Wood One Co., Ltd. | Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia |
US8124138B2 (en) * | 2006-08-10 | 2012-02-28 | Mimozax Co., Ltd. | Composition for prevention and/or treatment of pruritus containing acacia bark derivative |
FR2906442B1 (fr) * | 2006-10-02 | 2010-12-17 | Gervais Danone Sa | Utilisation de la gomme arabique pour ameliorer la croissance et la survie des bifidobacteries. |
JP2009203209A (ja) | 2008-02-29 | 2009-09-10 | Mimozax Co Ltd | アカシア属樹皮由来物を含有する血糖降下及び/又は抗肥満組成物 |
CN102836421A (zh) * | 2008-07-10 | 2012-12-26 | 狮王株式会社 | 肠内环境改善剂 |
JP2010105923A (ja) | 2008-10-28 | 2010-05-13 | Mimozax Co Ltd | アカシア属樹皮由来物を含有するPPARδ発現促進剤 |
JP2011051992A (ja) | 2010-10-05 | 2011-03-17 | Wood One:Kk | 活性酸素消去剤 |
WO2013073644A1 (ja) * | 2011-11-14 | 2013-05-23 | 塚原 順子 | 多種類のミネラルを含む複合康機能性食品 |
CN108697773B (zh) * | 2016-02-18 | 2022-11-22 | 天野酶制品株式会社 | 肠内菌群改善剂 |
-
2019
- 2019-10-04 JP JP2019183809A patent/JP2021059508A/ja active Pending
-
2020
- 2020-09-30 WO PCT/JP2020/037091 patent/WO2021065987A1/ja unknown
- 2020-09-30 EP EP20871159.8A patent/EP4039262A4/en active Pending
- 2020-09-30 CN CN202080069943.3A patent/CN114502186A/zh active Pending
- 2020-09-30 US US17/766,044 patent/US20220370533A1/en active Pending
- 2020-09-30 KR KR1020227012433A patent/KR20220062388A/ko unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002003388A (ja) * | 2000-06-20 | 2002-01-09 | Nof Corp | 便秘解消剤組成物 |
JP2009120508A (ja) * | 2007-11-13 | 2009-06-04 | Mimozax Co Ltd | アカシア属樹皮由来物を含有する便通改善用組成物 |
JP2009161502A (ja) * | 2008-01-10 | 2009-07-23 | Rikomu:Kk | 腸内菌叢改善剤及び食品 |
JP2013249276A (ja) * | 2012-05-31 | 2013-12-12 | Tsutsumi Planning:Kk | 機能食品 |
Non-Patent Citations (3)
Title |
---|
HARA, H., ET AL.: "Effect of Tea Polyphenols on Fecal Flora and Fecal Metabolic Products of Pigs", J. VET. MED. SCI., vol. 57, no. 1, JPN6020046215, 1995, pages 45 - 49, XP055811615, ISSN: 0004891495 * |
MORENO-INDIAS, I., ET AL.: "Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese", FOOD FUNCT., vol. vol.7, issue 4, JPN6020046217, 2016, pages 1775 - 1787, XP055811612, ISSN: 0004891496 * |
小川壮介ほか: "アカシア樹皮抽出物のヒトでの過剰摂取における安全性評価試験—プラセボ対照二重盲検無作為化並行群間比較", 薬理と治療, vol. 45, no. 12, JPN6020046214, 2017, pages 1927 - 1934, ISSN: 0004891494 * |
Also Published As
Publication number | Publication date |
---|---|
CN114502186A (zh) | 2022-05-13 |
EP4039262A1 (en) | 2022-08-10 |
KR20220062388A (ko) | 2022-05-16 |
WO2021065987A1 (ja) | 2021-04-08 |
EP4039262A4 (en) | 2023-12-20 |
US20220370533A1 (en) | 2022-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier | |
Whelan et al. | The impact of Bacillus subtilis DSM 32315 on the pathology, performance, and intestinal microbiome of broiler chickens in a necrotic enteritis challenge | |
TWI568360B (zh) | The use of cashew nut shell oil | |
Wan et al. | Recombinant plectasin elicits similar improvements in the performance and intestinal mucosa growth and activity in weaned pigs as an antibiotic | |
George et al. | Pomegranate peel extract alters the microbiome in mice and dysbiosis caused by Citrobacter rodentium infection | |
Finegold et al. | Pomegranate extract exhibits in vitro activity against Clostridium difficile | |
Betancourt et al. | Effect of Origanum chemotypes on broiler intestinal bacteria | |
Su et al. | Dietary supplementation of plant essential oil improves growth performance, intestinal morphology and health in weaned pigs | |
Li et al. | Macleaya cordata helps improve the growth-promoting effect of chlortetracycline on broiler chickens | |
Ruiz et al. | Effects of feed additives on ileal mucosa–associated microbiota composition of broiler chickens | |
Faber et al. | The effects of a galactoglucomannan oligosaccharide-arabinoxylan (GGMO-AX) complex in broiler chicks challenged with Eimeria acervulina | |
Fahle et al. | Antibacterial effects of biologically active ingredients in hop provide promising options to fight infections by pathogens including multi-drug resistant bacteria | |
Kettunen et al. | Natural resin acid–enriched composition as a modulator of intestinal microbiota and performance enhancer in broiler chicken | |
Kim et al. | Non-starch polysaccharide-degrading enzymes may improve performance when included in wheat-but not maize-based diets fed to broiler chickens under subclinical necrotic enteritis challenge | |
CN109688832B (zh) | 家畜用饲料或家畜用补充剂、乳杆菌属细菌的生长促进剂以及乳杆菌属细菌的生长促进方法 | |
WO2021065987A1 (ja) | 腸内環境改善剤 | |
Diotallevi et al. | Ex vivo fecal fermentation of human ileal fluid collected after wild strawberry consumption modulates human microbiome community structure and metabolic output and protects against DNA damage in colonic epithelial cells | |
JP2015218130A (ja) | 腸内フローラ調整能を有するイネ科植物抽出物 | |
US11607433B2 (en) | Composition for preventing, improving, or treating autism spectrum disorders including Agathobaculum sp. strain as active ingredient | |
JP7293406B2 (ja) | コリネバクテリウム属菌株およびその培養物を含む胃腸疾患予防、治療または改善用組成物 | |
WO2022036181A1 (en) | Microbial compositions to increase the production of pca from polyphenols | |
JP7283216B2 (ja) | 経口組成物 | |
JP7262391B2 (ja) | フソバクテリウム属細菌および/またはステレラ属細菌の菌数抑制剤 | |
KR102065180B1 (ko) | 클로스트리디오이데스 디피실레에 항균 활성을 갖는 락토바실러스 속 WiKim0092 균주 및 이를 포함하는 조성물 | |
KR20220079092A (ko) | 신규 균주를 포함하는 염증성 질환 예방 또는 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210524 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220607 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220712 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20221007 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20221215 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20221215 |
|
C116 | Written invitation by the chief administrative judge to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C116 Effective date: 20230111 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20230111 |